Heron Therapeutics Inc (HRTX)

R&D Expense Growth

13.29%

Quarterly · Period ending:

HRTX logo

HRTX R&D Expense Growth

Latest reported13.29%
HRTX Quarterly R&D Growth (QoQ) (0.00% → 13.29%)
High-resolution chart · PNG

HRTX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
12.0464%
-9.2227%
92.0802%
-7.0931%
-4.6643%
-59.4433%
120%
0%
-9.0909%
-8.3333%
20%
-16.6667%
20%
0%
11.1111%
0%
0%
50%
-40%
0%
11.1111%
-25%
33.3333%
-10%
11.1111%
-40%
-11.7647%
-10.5263%
46.1538%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.